chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started having red rashes arise and I wasn't certain when it started what was affecting me. And this went on for weeks, I treated it with cortisone cream, BENADRYL, and they would after a few days subside. But they kept coming back. I had them on my face and lower neck area and on my upper arm. I went to a Dermatologist and she thought it was some kind of contact dermatitis. She gave me a couple of prescriptions and scalp foam. After the 4th COVID-19 shot I got a really red rash on my forearm from touching a mat at the gym. After hair coloring (something I did for 10 years), now every time after I get a big red rash around my hairline. It's some form of contact reaction that I can just get when I touch certain things. The only thing I can pin it to because I've never had any allergies is the vaccination because that's the only new change in my life.
Had A-Fib event requiring hospitalization on 2/16/21.  Received TEE and heartversion
chills; fever; This case was reported by a other health professional via call center representative and described the occurrence of chills in an unknown number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced chills and fever. On an unknown date, the outcome of the chills and fever were unknown.   It was unknown if the reporter considered the chills and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication The physician assistant mentioned that he had seen patients reporting chills and fever after getting the Shingrix vaccine. No additional details on the patient. The reporter was in a hurry to get answers about patient having side effects that were reported during this call.
Chills; body aches; Massive right axillary adenopathy (10cm); headache; This is a spontaneous report from a contactable physician reporting for himself. A 62-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), intramuscular in the right arm, on 07Jan2021 at 04:00 PM, at single dose, for COVID-19 immunisation. Medical history was none. Concomitant medications were not reported. Previously, on 21Dec2020 at 05:00 PM, the patient received the 1st dose of bnt162b2, intramuscular in right arm. The patient experienced chills, body aches, massive right axillary adenopathy (10cm), headache all on 08Jan2021 at 04:00 AM with outcome of recovering. The events required physician office visit. The patient was not tested for COVID-19 post vaccination.  The information on the lot/batch number has been requested.
Muscle pain, headache, body chills, shaking, fatigue, fever, fainting
My first moderna vaccine about 3 weeks later I had a stroke; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (My first moderna vaccine about 3 weeks later I had a stroke) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (My first moderna vaccine about 3 weeks later I had a stroke) (seriousness criteria hospitalization, medically significant and life threatening). At the time of the report, CEREBROVASCULAR ACCIDENT (My first moderna vaccine about 3 weeks later I had a stroke) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       About 3 weeks after receiving the first dose of vaccine, the patient had a stroke. The patient's concomitant medication was not reported. No treatment information was provided.  Very limited information regarding this event has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0183), via an unspecified route of administration in right arm, on 14May2021 at 10:00 (at the age of 55-years-old) as first dose, single for COVID-19 immunization in a hospital. Medical history included rheumatoid arthritis, asthma, hypertension and medullary sponge kidneys. The patient had known allergies. The patient had concomitant medications but not reported. The patient was not pregnant and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient's both feet feel like having pins and needles and feel asleep on 14May2021 at 10:45. No treatment was received by the patient for these events. The outcome of these events was not recovered at the time of report.   No follow-up attempts are possible. No further information is expected.
Filing this report due to an administration error not associated with an adverse event.  Employee was administered second dose earlier than the recommended timeframe.  First dose administered 2/26 and second dose administered 3/25. Employee has not had a physical adverse reaction, and no treatment has been sought.
pt lives in a nursing home; had a positive COVID test on 1/13/22; cough; on O2; per death certificate, pt died in the facility with COVID 19 being the cause of death
Pt recvd vax 27JAN92; Notified on 30JAN92 by parents that pt had expired; clinic requested that VAERS form be completed;
Pt. phoned 2/15/12 to schedule next in series of travel vaccines. Reported "itchy rash" on "back" of (R) arm "between shoulder and elbow" & using OTC "hydrocortisone cream" for relief. Said rash persisting over past "2 weeks".
On 08/25/19, I received dose 2 of Shingrix. Pharmacy has this date wrong in their system. Within a couple of hours I was beginning to feel very ill. By night, I was sweating, freezing, running 101.5 fever, terrible pain in arm, vomiting, congestion all night. Almost went to ED. The next day and subsequent days very fatigued. A rash and pox like thing erupted at the injection site on my left arm. It was horribly painful. By mid-September, I am still feeling terrible and my arm is worse, I make an appt. with my primary care. She sends me to a Derma Surgeon specializing in Mohs surgery. She does biopisies. My arm, has rare form of squamous cell cancer that erupts upon trauma. 2 surgeries and more spots appearing.
Same symptoms as first dose adverse reaction, but much worse. I had a lot of pain, chills and little bit of fever and lot of body pain. Very fatigue and could get out of bed. "My body was out of me". By Monday I was okay, just pain in my shoulders and especially in my arms. Dose 3 adverse reactions were much more severe. However, this dose was given in Regulatory Authority. The doctor sent me to a physical therapist for the pains in my bones, but it did not help.
Patient stated he took some energy drinks. Patient was observed and assessed. Vitals: temperature 98.1, blood pressure 134/80 and oxygen 98%. Gave water and crackers. Patient felt better and was able to drive home.
Smallpox vaccine was administered on 29Dec2013 and by report, pt developed multiple pruritic erythematous macule vs plaques (? hives) that resolved with topical steroids. I evaluated this pt for the first time on 3Feb2014 where he was asymptomatic except for multiple hyperpigmented macules presumably at site of prior ? hives.
VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8° (10 mins); This non-serious spontaneous report with reference numbers 02197725 / 02197588 was received by partner on 05-JUL-2022 and forwarded on 06-JUL-2022 from a consumer.    The causal relationship between Vaxelis and the reported event "multiple doses of VAXELIS administered since temperature excursion" was assessed as not applicable due to the nature of the event.    Further information is expected.  FOLLOW-UP INFORMATION was received by a partner on 01-AUG-2022 and forwarded on 03-AUG-2022, from a HCP. The case is maintained as non-serious.  The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient.  Due to the nature of the event, the causality between the event "VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins)" and Vaxelis remained not applicable.  For reference purposes this case is linked to MCM-003724, MCM-003725, MCM-003726, MCM-003724, MCM-003734, MCM-003735, MCM-003737, MCM-003738, MCM-003739, MCM-003740, MCM-003741, MCM-003742, MCM-003743, MCM-003744, MCM-003747, MCM-003749, MCM-003751, MCM-003752, MCM-003753, MCM-003757, MCM-003759, MCM-003760, MCM-003763, MCM-003766, MCM-003761, MCM-003769, MCM-003770, and MCM-003772, due to same reporter.  No further information is expected.
My daughter got an intractable headache the Tuesday after getting the vaccine.  The headache was not treatable through normal pain relievers such as Tylenol and Ibuprofen.  The pediatrician told us to take her to the ER.  At the ER, they tested her for intercranial hypertension, as she had no history of migraines in the past.  The tests turned out negative.  They tried the normal migraine cocktail, Depakote, Decadron and magnesium.  None of the typical treatments worked to relieve the headache.  She was admitted to the hospital.  She had a neurology consultation, which didn't show any neurological issues.  The doctor also did an MRI.   The MRI didn't show anything abnormal.  The doctor started her on DHE (dihydroergotamine).  The medication began to help relieve the headache.  My daughter could not tolerate 0.5mg DHE, so the doctor gave her 2 more 0.4mg DHE treatments which eventually brought the headache down to a pain level of 0.
Patient developed severe myalgia, headache, and lethargy the morning following vaccine administration. Developed a fever of 103.8 and vomitting later that same morning. Has managed some symptoms with regular administration of Tylenol/Motrin (every hour).
A week later I noticed my arm is itching and when I looked at it, it was swollen and red. It was itching like crazy. I went to the doctor. I went to my doctor's office and she prescribed a cream for the itching and told me to put ice on it.
May 4, 2021 aprox. 23 hours after the vaccine I became very cold (not chills) and sleepy/tired. Lasted aprox  6 hours. Then between 10pm and 7am I had night sweats.
Patient had gotten a vaccination 2 days prior.  Came in to the pharmacy, said that she had been having a warm sensation where she received her two vaccines.  The area was red, uncomfortable and itchy.  It was not bruised, but diffuse red area she said had become larger the day before. I asked if she had ever had a reaction to a vaccine before, if she had noticed any bruising.  She said she had not.  I confirmed she didn't have any allergic reaction symptoms (swelling of lips or tongue, SOB, hives).  I told her to try to ice it and take an allergy tablet to reverse possible allergic reaction.   I followed up with her the next afternoon, she said she did those treatment measures but it remained unchanged.  I told her it may take a week or longer for the symptoms to subside, but call us after a week if it was not staying the same or getting better.  Patient will monitor and follow up if she things its not improving.
WHILE ADMINISTERING THE VACCINE, THE MAJORITY OF THE VACCINE LEAKED OUT OF THE SYRINGE AT THE NEEDLE JUNCTION. THE NEEDLE IS NOT SUPPOSED TO COME APART FROM SYRINGE OR NEED TO BE TIGHTENED AS THEY ARE SEALED, SO THE SYRINGE MALFUINCTIONED. SINCE MOST OF THE VACCINE WAS NOT ADMINISTERED, PT MOM DECICED TO RE-VACCINMATE AFTER DISCUSSING WOTH THR RPH THROUGH SHARED CLINICAL DECISION MAKING. NO ADDITION ADVERSE EVENT HAVE BEEN REPORTED SINCE
Five minutes after patient received vaccine, she felt faint and vomited. Pupils were dilated, and she was cold and clammy.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and gender. The patient medical history and concurrent conditions were not provided. On an unknown date, a different patient was vaccinated with a dose of M-M-R II, (route, lot # and expiration date were not provided). On an unknown date, the patient, whose age and gender was unknown, experienced secondary transmission and measles described by the physician as the patient contracted vaccine associated measles from the patient that had received the M-M-R II. It was unknown if medical attention was sought. At the time of the report, the patient status was unknown. The physician also mentioned that she had seen unspecified patients that were administered an unspecified flu vaccine on unspecified dates and the unspecified patients contracted the flu virus. The physician believed this was vaccine failure of the most recent unspecified flu vaccine. This is one of several reports received from the same source. Additional information is not expected. The physician did not authorize to be contacted.
Patient presented with a red, swollen upper arm. The upper arm was warm to the touch and injection site looked good. Recommended ice and BENADRYL. Called patient later that day who reported it was subsided a bit in redness.
Case number PHEH2013US016630, is an initial spontaneous report received from the pharmacist on 01 Aug 2013. This report refers to an unspecified age and gender patient. Past medical history and concomitant medication were not reported. From after hours on 01 Aug 2013, pharmacist reported that, a patient was vaccinated with double dose of MENVEO (batch number: not reported), intramuscularly on an unspecified date. No adverse event was reported following this administration error.
Pt presents a red rash wrapping around the arm into the lymph nodes. The lymph nodes and arm is swollen. Pt was nauseous.
Fever, CoughWheeze, Syncope, fatigue, body ache, sore throat, Narrative:
severe muscle pain; This case was reported by a consumer via call center representative and described the occurrence of myalgia in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th August 2022, the patient received Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced myalgia. On an unknown date, the outcome of the myalgia was unknown.   It was unknown if the reporter considered the myalgia to be related to Shingrix.     Additional Information: GSK Receipt Date: 03-OCT-2022 Reporter's Comments: The patient had the Shingrix vaccine and had severe muscle pain. The patient said that please advise.
This case was reported by a healthcare professional and described the occurrence of inappropriate schedule of drug administration in a subject of unspecified age and gender who was vaccinated with Engerix-B (GlaxoSmithKline) and hepatitis B vaccine. The subject's medical history included heart disease. Concurrent medical conditions included hypertension. Concurrent medications included Clonidine, Flopen, Isodine, Aspirin and HCTZ. On an unspecified date, prior to 22 January 2007, the subject received an unspecified dose of Hepatitis B vaccine (unknown). At an unspecified time after vaccination with Hepatitis B vaccine, the subject experienced a "really sore" arm. At the time of reporting, the outcome of the event was unspecified. On 22 January 2007, the subject received the 3rd dose of Engerix-B (unknown, left arm) approximately 60 days early. The subject was supposed to receive the vaccination in March 2007. The subject was supposed to have blood work performed, but she requested vaccination for Hepatitis B.
Information has been received from a Doctor of Pharmacy concerning his approximately 8 month old son, a twin born premature, who in approximately November 2007, was vaccinated in the leg with a dose of COMVAX (lot 657380/0377U).  The patient was concomitantly vaccinated with unknown multiple vaccines at the same office visit.  Subsequently, the patient developed a red area at the injection site that lasted 4-5 days.  Subsequently, the patient recovered.   Additional information has been requested.
I experienced  fatigue Saturday night, which I somewhat expected. I took Tylenol and was able to sleep well. Sunday morning I was sill tired but able to function.  I experienced dizziness on Sunday morning while helping my mother get dressed. I thought it could have been attributable to bending over and standing up repeatedly.  On Monday, I again experienced dizziness as I worked at my standing desk. I also became flushed - began sweating, my glasses fogged up. I sat down and put my head down. I felt that if I tried to walk I would faint. It took several minutes - as many as 5 - for this to resolve.
No adverse event; the 1st dose of the bivalent vaccine from the pink cap with a yellow label vial last 04May2023; This spontaneous case was reported by a physician and describes the occurrence of WRONG PRODUCT ADMINISTERED (the 1st dose of the bivalent vaccine from the pink cap with a yellow label vial last 04May2023) and NO ADVERSE EVENT (No adverse event) in a 6-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     No relevant medical history/conditions, allergy, concomitant diseases and risk factor.     On 04-May-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .2 milliliter. On 04-May-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (the 1st dose of the bivalent vaccine from the pink cap with a yellow label vial last 04May2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (the 1st dose of the bivalent vaccine from the pink cap with a yellow label vial last 04May2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (the 1st dose of the bivalent vaccine from the pink cap with a yellow label vial last 04May2023).    The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication not reported.  Treatment medication not reported.
Extremely high glucose levels that occurred all of a sudden and went into DKA with vomiting over 20 times in 4 hrs. Dehydration and headaches prolonged as well as esophagus tearing.
The patient received the vaccine on 1-21-21 and 1-27-2021. There were no symptoms associated with receiving the vaccine before the 28 days. Patient was monitored for 30 minutes or more and no reactions were noted.
Patient had the second shot 1/12. Experienced numbness of feet within first 24 hrs. That continued up both legs and then weakness set in. Called PCP on the 15th as symptoms were getting worse not better. Patient advised me to go to ED. Went to ED here last Friday and was released. The weakness in legs got much worse and early the following week she started getting the numbness and weakness in arms. She went for the follow up post ED visit with NP at PCP office on 1/20 and due to the continued weakness, after consulting with one of the MDs, decision was made to send her back to ED for further work up to check for GBS including the LP in ED, labs and MRI of head, spine, lumbar and thoracic. Patient was release on Saturday 1/23 and diagnosis was a severe immune response to the vaccine.  Patient still has unsteady gait and weakness.
The patient experienced itching on various sites of body. There was slight redness of injection site and itching at the injection site. The pharmacist recommended Benadryl. Overall, the patient seemed to be fine.
Headache began Friday, continued Saturday, relieved with Tylenol, gone by Saturday PM. Hives started on Sunday, 4/30/00, on arms from mid bicep to wrists; relieved with Benadryl PO, decreased by Monday, 5/12/00. Hives on outer aspect of both legs from mid thigh to ankles began Monday 5/1/00 at 08:00 and descreased use of Benadryl. No respiratory problems.
Within 2-3 hours of vaccination, patient was unable to lift arm. Pain has continued thru March 2015 despite course of physical therapy.
lt upper arm swollen, 33 x 3; discolored, purpulish, red, tender;
whistle-pitch involuntary noises while nursing crying w/o making a sound, staring, unresponsiveness for the next 1 1/2wk;fever & sz on 10OCT96 lasting 45min;started focal then progressed to grand mal sx;
Unexplained one time severe diarrhea the day after in afternoon.  Small bowel movement two days later was normal . Had flu shot in October. Arm pain minimal and one day only.
Pt 1 of 9 from total of 191 pts who completed series of 3 Hep B vax and did not achieve immunity.Pt did not seroconvert.
A few hours after vaccination, I had a 101.9 degree fever and intense leg pains. The fever lasted a total of approximately 21 hours. Leg pains and overall fatigue lasted approximately 48 hours.
Vaccinated 1-27-14, symptoms occurred after 2/7/14 -> hot/cold sweats, fever on/off (not measured), neck/back pain, consistent weakness on all limbs, especially left arm. Stiff neck, (some) difficulty breathing (SOB). White of eyes changed to slight blue, excess thirst, tingling joints, clammy feeling.
Last Saturday about noon my nose started running. The next day I developed a cough. I took ROBITUSSIN and TYLENOL.  I took that Sunday and Monday. On Tuesday I still had the cough and my head began to hurt around my eyes. I began to get stuffy. Then my ear stopped up and began popping. I went to the ER Tuesday evening. I was wheezing and my ear looked infection. I began to spit up phlegm that was white and then yellow. My ear continued to hurt. COVID-19 test at the ER was positive. As of today I still have symptoms, coughing. I was advised to take zinc and vitamin C.
vomiting x 1 episode, with hives like rash on forehead few hours after vaccine that resolved 24 hours after
It was reported that a 45 year old female patient received a Fluzone SV vaccination on 11/29/2000. Approximately one hour after vaccination the patient became wheezy, developed a fever of 102F, muscle aches and chills. Further information is requested.
Body tremors; Ear piercing screams; High fever; This case was reported by a consumer via interactive digital media and described the occurrence of tremor in a female patient who received DTP (A or W not known) (DTP (A or W not known)) for prophylaxis.   On an unknown date, the patient received the 1st dose of DTP (A or W not known). On an unknown date, unknown after receiving DTP (A or W not known), the patient experienced tremor, screaming and fever. On an unknown date, the outcome of the tremor, screaming and fever were unknown.   It was unknown if the reporter considered the tremor, screaming and fever to be related to DTP (A or W not known).  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient was 3 at the time, had no complications. The reporter reported that, the pediatrician would not administer another dose to the patient and subsequently making the patient potentially vulnerable to whooping cough. This case has been linked with case US2019AMR234293, reported by same reporter.